V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004638 | 300003230 | 1.49 | 54.8 | Neo-adjuvant (N) | 2017-02-18 | 2017-03-30 | FLUOROURACIL + MITOMYCIN | Y | N | 300024713 | CAPECITABINE + GEMCITABINE |
| 300004639 | 300003230 | 1.68 | null | Curative (C) | 2017-07-31 | 2017-07-31 | Folfirinox | N | Y | 300024713 | LENALIDOMIDE |
| 300004640 | 300003230 | 1.52 | null | Palliative (P) | 2017-05-19 | 2017-06-11 | Gemcitabine + Capecitabine | N | N | 300024713 | CARBOPLATIN |
| 300004641 | 300003231 | 1.76 | 74.4 | Curative (C) | 2014-05-06 | 2014-06-01 | Carboplatin AUC 2 - 5 | Y | N | 300024728 | CISPLATIN + ETOPOSIDE |
| 300004642 | 300003231 | 1.57 | 58.2 | null | 2015-10-24 | 2015-10-25 | PEMBROLIZUMAB | N | null | 300024728 | CARBOPLATIN |
| 300004643 | 300003232 | 1.92 | null | Palliative (P) | null | 2013-09-09 | CARBOPLATIN + GEMCITABINE | null | N | 300024739 | DE-ESCALATE TRIAL |
| 300004644 | 300003233 | 1.78 | null | Curative (C) | 2015-11-20 | 2015-11-24 | CARBOPLATIN + RT | N | null | 300024746 | CARBOPLATIN + RT |
| 300004645 | 300003233 | 1.6 | 65.2 | Adjuvant (A) | 2016-09-30 | 2016-10-17 | ESPAC-4 TRIAL | N | N | 300024746 | GEMCARBO |
| 300004646 | 300003233 | 1.52 | null | Disease modification (D) | null | 2014-06-25 | Cisplatin + Etoposide (3 day) | N | N | 300024746 | CARBOPLATIN |
| 300004648 | 300006164 | 0 | 95.1 | Adjuvant (A) | 2017-02-13 | 2017-02-27 | Carbo F | 2 | N | 300024775 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004649 | 300003235 | null | 87.4 | Curative (C) | null | 2017-04-12 | Docetaxel | null | Y | 300024777 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 300004650 | 300003235 | 1.84 | 95.1 | Curative (C) | 2013-06-28 | 2013-07-07 | CARBOPLATIN + RT | 01 | N | 300024777 | CAPECITABINE + OXALIPLATIN |
| 300004651 | 300003236 | 1.47 | 85.45 | Adjuvant (A) | 2014-05-09 | 2014-05-10 | Folfirinox | N | N | 300024784 | CARBOPLATIN |
| 300004652 | 300006166 | null | null | Adjuvant (A) | null | 2017-09-17 | VAI (Ifos 3g/m2) | null | null | 300024788 | PEMBROLIZUMAB |
| 300004653 | 300006166 | 1.75 | 55.8 | Palliative (P) | null | 2015-03-21 | CARBOPLATIN + RT | 02 | N | 300024788 | TRASTUZUMAB |
| 300004654 | 300006166 | 1.72 | 83 | Palliative (P) | 2017-04-06 | 2017-04-06 | CARBOPLATIN + RT | 02 | N | 300024788 | CISPLATIN + ETOPOSIDE |
| 300004655 | 300003237 | 1.78 | 87.1 | Palliative (P) | 2013-07-03 | 2013-07-09 | Carboplatin AUC 2 - 5 | Y | N | 300024793 | HYDROXYCARBAMIDE |
| 300004656 | 300003238 | 0 | 63.7 | Palliative (P) | 2016-08-01 | 2016-08-02 | ESPAC-4 TRIAL | 1 | N | 300024801 | CAPECITABINE + GEMCITABINE |
| 300004657 | 300003238 | 1.56 | 63.7 | Adjuvant (A) | 2015-08-08 | 2015-08-21 | ESPAC-4 TRIAL | 2 | N | 300024801 | EC |
| 300004658 | 300003238 | null | null | Curative (C) | 2017-05-25 | 2017-06-08 | Oxaliplatin + Modified de Gramont | 2 | Y | 300024801 | GEFITINIB |
| 300004660 | 300006168 | 1.55 | 86.7 | Neo-adjuvant (N) | 2013-07-07 | 2013-07-07 | Carboplatin AUC 2 - 5 | 2 | N | 300024828 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004662 | 300003241 | 1.79 | 89 | null | 2015-09-17 | 2015-09-18 | CHOP R - 21 days | 2 | Y | 300024836 | CAPECITABINE + CARBOPLATIN |
| 300004663 | 300003241 | 1.62 | 54 | Adjuvant (A) | null | 2015-09-25 | Carboplatin AUC 6 - 10 | N | N | 300024836 | CARBOPLATIN + ETOPOSIDE |
| 300004664 | 300003241 | 1.67 | 97.6 | Neo-adjuvant (N) | 2014-06-03 | 2014-06-11 | EP | N | N | 300024836 | GEMCARBO |
| 300004665 | 300003242 | 1.66 | 72.9 | Neo-adjuvant (N) | 2016-03-10 | 2016-04-02 | CARBOPLATIN + FLUOROURACIL | Y | N | 300024853 | CAPECITABINE + GEMCITABINE |
| 300004668 | 300003244 | null | null | Palliative (P) | 2014-01-04 | 2014-02-04 | CARBOPLATIN + RT | N | N | 300024859 | CARBOPLATIN + RT |
| 300004669 | 300003245 | 1.76 | null | Adjuvant (A) | 2015-01-13 | 2015-02-14 | ABVD | N | N | 300024861 | CARBOPLATIN |
| 300004670 | 300006171 | 1.74 | 80 | Palliative (P) | 2015-02-21 | 2015-02-26 | EC | N | N | 300024875 | NOT MATCHED |
| 300004671 | 300006171 | 1.61 | null | Adjuvant (A) | 2016-10-14 | 2016-10-20 | FLUOROURACIL + MITOMYCIN | 02 | N | 300024875 | FLUOROURACIL |
| 300004672 | 300006171 | 1.61 | 54.2 | Curative (C) | 2015-03-05 | 2015-03-31 | Cisplatin + Etoposide po&iv 3 day | Y | Y | 300024875 | CAPECITABINE + GEMCITABINE |
| 300004674 | 300003247 | 1.77 | 66 | Palliative (P) | null | 2016-04-20 | Carbo F | N | N | 300024887 | ESPAC TRIAL |
| 300004675 | 300003247 | 1.62 | 88.3 | Palliative (P) | 2015-09-26 | 2015-09-26 | Irinotecan + Modified De Gramont | 02 | N | 300024887 | CARBOPLATIN |
| 300004676 | 300007490 | null | 77.8 | Curative (C) | 2017-07-26 | 2017-07-29 | CAPECITABINE + OXALIPLATIN | N | Y | 300024890 | CARBOPLATIN + ETOPOSIDE |
| 300004677 | 300003248 | 0 | 53.7 | Curative (C) | 2015-07-09 | 2015-07-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 300024898 | CARBOPLATIN + RT |
| 300004679 | 300003249 | 1.72 | 58.4 | Curative (C) | 2015-11-13 | 2015-11-29 | Folfirinox | 02 | null | 300024904 | DE-ESCALATE TRIAL |
| 300004680 | 300003249 | 1.61 | 66.3 | Adjuvant (A) | 2017-10-27 | 2017-10-27 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 300024904 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004681 | 300003250 | 1.7 | 53.9 | Palliative (P) | 2015-03-11 | 2015-03-11 | CARBOPLATIN + ETOPOSIDE | 2 | N | 300024915 | CAPECITABINE + GEMCITABINE |
| 300004683 | 300003252 | 1.68 | 47.9 | Curative (C) | 2015-10-08 | 2015-10-08 | FLUOROURACIL | 02 | null | 300024921 | GEMCARBO |
| 300004684 | 300003253 | 1.54 | 50.3 | Curative (C) | 2014-04-06 | 2014-04-07 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | 300024922 | HYDROXYCARBAMIDE |
| 300004685 | 300003253 | null | 52.7 | Adjuvant (A) | 2015-04-24 | 2015-05-05 | Bevacizumab | N | N | 300024922 | OXALIPLATIN + MDG |
| 300004686 | 300007491 | 1.78 | 89 | Adjuvant (A) | 2014-11-26 | 2014-12-02 | CompARE Trial | 02 | N | 300024930 | CARBO + FLUOROURACIL |
| 300004687 | 300003254 | 1.85 | 59.3 | Palliative (P) | 2016-03-24 | 2016-03-26 | CHOP R - 21 days | 01 | N | 300024933 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004688 | 300006176 | 1.68 | 75.3 | Neo-adjuvant (N) | 2014-07-17 | 2014-07-17 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 300024938 | RITUXIMAB |
| 300004689 | 300003255 | 1.59 | 70 | Adjuvant (A) | 2014-05-07 | 2014-05-11 | PEMBROLIZUMAB | 02 | N | 300024942 | BEVACIZUMAB |
| 300004690 | 300003256 | 1.89 | 100 | Palliative (P) | 2014-11-18 | 2014-12-08 | GEMCARBO | N | N | 300024944 | GEMCARBO |
| 300004691 | 300003256 | 1.55 | 52.7 | Palliative (P) | 2016-07-31 | 2016-08-18 | ESPAC-4 TRIAL | N | N | 300024944 | FLUOROURACIL + MITOMYCIN |
| 300004692 | 300003257 | null | null | Not known (9) | 2017-11-28 | 2017-12-14 | FLUOROURACIL + MITOMYCIN | N | N | 300024948 | FLUOROURACIL + MITOMYCIN + RT |
| 300004694 | 300003259 | 1.74 | 104.4 | Palliative (P) | 2015-09-14 | 2015-09-24 | Gemcitabine + Capecitabine | 2 | N | 300024964 | CARBOPLATIN + ETOPOSIDE |
| 300004695 | 300003259 | 1.57 | null | Curative (C) | 2015-12-06 | 2015-12-23 | Capecitabine + Oxaliplatin 21day | N | Y | 300024964 | FLUOROURACIL + MITOMYCIN |
| 300004696 | 300003260 | 1.6 | 65.7 | Curative (C) | 2017-03-08 | 2017-03-08 | ESPAC-4 TRIAL | 02 | N | 300024968 | EOX |